Construction and validation of nomogram prediction model for recurrent spontaneous abortion based on the expression of MALAT1, miR-515-5p, and MCL1 mRNA.
1/5 보강
[OBJECTIVE] To investigate the construction and clinical application value of Nomogram predictive model for recurrent spontaneous abortion (RSA) based on the expressions of MALAT1 (Metastasis Associat
- 95% CI 0.858-0.974
APA
Chen X, Wang X, et al. (2025). Construction and validation of nomogram prediction model for recurrent spontaneous abortion based on the expression of MALAT1, miR-515-5p, and MCL1 mRNA.. Frontiers in medicine, 12, 1558818. https://doi.org/10.3389/fmed.2025.1558818
MLA
Chen X, et al.. "Construction and validation of nomogram prediction model for recurrent spontaneous abortion based on the expression of MALAT1, miR-515-5p, and MCL1 mRNA.." Frontiers in medicine, vol. 12, 2025, pp. 1558818.
PMID
41480526 ↗
Abstract 한글 요약
[OBJECTIVE] To investigate the construction and clinical application value of Nomogram predictive model for recurrent spontaneous abortion (RSA) based on the expressions of MALAT1 (Metastasis Associated Lung Adenocarcinoma Transcript 1), miR-515-5p, and MCL1 (Myeloid Cell Leukemia-1) mRNA.
[METHODS] According to the 7:3 ratio, the patients were divided into the training set ( = 135) and the validation set ( = 58) by the complete random method. In the training set, multivariate Logistic regression was used to analyze the risk factors for RSA and a Nomogram prediction model was constructed based on the expressions of MALAT1, miR-515-5p, and MCL1 mRNA. The receiver operating characteristic (ROC) curve and calibration curve were drawn to evaluate the prediction performance of the Nomogram model and verified in the validation set. At the same time, decision curve analysis (DCA) was used to evaluate the clinical application value of the Nomogram model.
[RESULTS] There were 38 cases (28.15%) of RSA in the training set and 17 cases (29.31%) in the validation set. During the training set, advanced maternal age, number of abortions >3, low progesterone level in early pregnancy, high expression of MALAT1, low expression of miR-515-5p and low expression of MCL1 mRNA were the independent risk factors for RSA ( < 0.05). We will further construct the Nomogram prediction model. In the training set and validation set, the C-index values of Nomogram model were 0.915 and 0.869, respectively. The calibration curve showed that the predicted values accorded well with the actual values, with the average absolute errors of 0.012 and 0.034, respectively. The values of Hosmer-Lemeshow test were 0.362 and 0.779, respectively, indicating that the model had good calibration and fitting performance. The ROC curve showed that the Nomogram models in the training and validation sets predicted AUC values for RSA to be 0.916 (95% CI, 0.858-0.974) and 0.867 (95% CI, 0.742-0.992), respectively.
[CONCLUSION] The Nomogram prediction model constructed based on the expressions of MALAT1, miR-515-5p, and MCL1 mRNA is helpful to predict the occurrence of RSA in the early stage and guide the making of appropriate clinical decisions.
[METHODS] According to the 7:3 ratio, the patients were divided into the training set ( = 135) and the validation set ( = 58) by the complete random method. In the training set, multivariate Logistic regression was used to analyze the risk factors for RSA and a Nomogram prediction model was constructed based on the expressions of MALAT1, miR-515-5p, and MCL1 mRNA. The receiver operating characteristic (ROC) curve and calibration curve were drawn to evaluate the prediction performance of the Nomogram model and verified in the validation set. At the same time, decision curve analysis (DCA) was used to evaluate the clinical application value of the Nomogram model.
[RESULTS] There were 38 cases (28.15%) of RSA in the training set and 17 cases (29.31%) in the validation set. During the training set, advanced maternal age, number of abortions >3, low progesterone level in early pregnancy, high expression of MALAT1, low expression of miR-515-5p and low expression of MCL1 mRNA were the independent risk factors for RSA ( < 0.05). We will further construct the Nomogram prediction model. In the training set and validation set, the C-index values of Nomogram model were 0.915 and 0.869, respectively. The calibration curve showed that the predicted values accorded well with the actual values, with the average absolute errors of 0.012 and 0.034, respectively. The values of Hosmer-Lemeshow test were 0.362 and 0.779, respectively, indicating that the model had good calibration and fitting performance. The ROC curve showed that the Nomogram models in the training and validation sets predicted AUC values for RSA to be 0.916 (95% CI, 0.858-0.974) and 0.867 (95% CI, 0.742-0.992), respectively.
[CONCLUSION] The Nomogram prediction model constructed based on the expressions of MALAT1, miR-515-5p, and MCL1 mRNA is helpful to predict the occurrence of RSA in the early stage and guide the making of appropriate clinical decisions.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (5)
- Rare fusion transcript in a refractory adult T-cell lymphoblastic lymphoma.
- Rabdosin B suppresses proliferation of nonsmall cell lung cancer by regulating the SRC/PI3K/AKT signaling pathway.
- Development of a chemiluminescence immunoassay for proGRP in human serum.
- Genetically encoded biosensors in microbes for Tumor targeting.
- Analysis of discordant results in multi-technique platform-based MRD detection in multiple myeloma and the clinical decision-making dilemma.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A stress granule-associated RNA-binding protein FAM120A drives cisplatin resistance in non-small cell lung cancer.
- The expression of MALAT1 long non-coding RNA is associated with good prognosis in mantle cell lymphoma.
- METTL3-mediated mA modification of lncRNA MALAT1 promotes colorectal cancer progression by activating the NF-κB signaling pathway.
- MALAT1 Gene Variants rs619586, rs664589, and rs3200401 and Their Association with Non-Hodgkin Lymphoma Risk: Evidence from a Case- Control Study in Southeast Iran.
- Patient-derived organoid xenografts reveal the multifaceted role of the lncRNA in breast cancer progression.
- Docetaxel and Gemcitabine Modulate Cellular Effects and Long Non-Coding RNA Profiles in Non-Small Cell Lung Cancer.